Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor‐induced destruction of red cells sensitized by IgG
- 1 July 1994
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 34 (7), 617-626
- https://doi.org/10.1046/j.1537-2995.1994.34794330018.x
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Evidence for the Protective Effect of Maternal FcR‐Blocking IgG Alloantibodies HLA‐DR in Rh D‐Haemolytic Disease of the NewbornVox Sanguinis, 1993
- Phagocytosis by Human Monocytes of Red Cells Sensitized with Monoclonal IgG1 and IgG3 Anti‐DVox Sanguinis, 1989
- Complement is not activated in ABO‐haemolytic disease of the newbornBritish Journal of Haematology, 1988
- Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assayTransfusion, 1987
- Heterogeneity of IgG1 monoclonal anti‐Rh(D): an investigation using ADCC and macrophage binding assaysBritish Journal of Haematology, 1987
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- CORRELATION OF IN VIVO ALLOANTIBODY SIGNIFICANCE OR INSIGNIFICANCE WITH AN IN VITRO MONOCYTE‐MACROPHAGE PHAGOCYTOSIS ASSAYBritish Journal of Haematology, 1986
- In vitro determination of red cell alloantibody significance using an assay of monocyte‐macrophage interaction with sensitized erythrocytesBritish Journal of Haematology, 1984
- PREDICTION OF THE SEVERITY OF RHESUS HAEMOLYTIC DISEASE OF THE NEWBORN BY AN ADCC ASSAYThe Lancet, 1981
- IgG4 Autoantibodies against Erythrocytes, without Increased Haemolysis: a Case ReportBritish Journal of Haematology, 1977